Treatment of premature menopause in breast cancer patients

Acta Chirurgica Belgica

Volumn 107, Issue 3, 2007, Pages 263-266

  Deniz, G ^a   Antoine, C ^a   Liebens, F ^a   Carly, B ^a   Pastijn, A ^a   Rozenberg, S ^a  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

Antidepressive agents; Breast cancer; Hormonotherapy; Menopause; Quality of life

Indexed keywords

EID: 34547261888     PISSN: 00015458     EISSN: 25770160     Source Type: Journal    
DOI: 10.1080/00015458.2007.11680053     Document Type: Review

References (34)

1. ANTOINE C., LIEBENS F., CARLY B., PASTIJN A., NEUSY S., ROZENBERG S. Safety of hormone therapy after breast cancer: a qualitative systematic review. Human reproduction, 2007 Feb. 22 (2) : 616-22. Epub 2006 Oct 18.
2. ANTOINE C., LIEBENS F., CARLY B., PASTIJN A., ROZENBERG S. Safety of alternative treatments for menopausal symptoms after breast cancer : a qualitative systematic review. Climacteric (In press).
3. BATUR P., BLIXEN C. E., MOORE H. C. F., THACKER H. L., XU M. Menopausal hormone therapy (HT) in patients with breast cancer. Maturitas, 2006, 53: 2123-132.
4. BURSTEIN H. J., WINER E. P. Primary care for survivors of breast cancer. N Engl J Med, 2000 Oct 12, 343 (15): 1086-94.
5. CHLEBOWSKI R. T., HENDRIX S. L., LANGER R. D., STEFANICK M. L., GASS M., LANE D., RODABOUGH R. J., GILLIGAN M. A., CYR M. G., THOMSON C. A. WHI and Investigators. Influence of oestrogen plus progestin on breast cancer and mammography in healthy postmenopausal women : the Women's Health Initiative Randomized Trial. JAMA, 2003, 289: 243243-3253.
6. COL N. F., HIROTA L. K., ORR R. K., ERBAN J. K., WONG J. B., LAU J. Hormone replacement therapy after breast cancer : a systematic review and quantitative assessment of risk. J Clin Oncol, 2001, 19: 82357-2363.
7. COL N. F., KIM J. A., CHLEBOWSKI R. T. Menopausal hormone therapy after breast cancer : a meta-analysis and critical appraisal of the evidence. Breast Cancer Res, 7: 4R535-R540 [Epub 19 May 2005].
8. DEW J. E., WREN B. G., EDEN J. A. A cohort study of topical vaginal oestrogen therapy in women previously treated for breast cancer. Climacteric, 2003, 6: 145-52.
9. DIMITRAKAKIS C., KERAMOPOULOS D., VOURLI G., GAKI V., BREDAKIS N., KERAMOPOULOS A. Clinical effects of tibolone in postmenopausal women after 5 years of tamoxifen therapy for breast cancer. Climacteric, 2005 Dec, 8 (4): 342-51.
10. FELLOWES D., FALLOWFIELD L. J., SAUNDERS C. M., HOUGHTON J. Tolerability of hormone therapies for breast cancer : how informative are documented symptom profiles in medical notes for 'well-tolerated' treatments ? Breast Cancer Res Treat, 2001 Mar. 66(1): 73-81.
11. GANZ P. A. Breast cancer, menopause, and long-term survivorship: critical issues for the 21 st century. Am J Med, 2005 Dec 19. 118 Suppl 12B: 136-41. PMID: 16414339.
12. GINSBURG J., PRELEVIC: G. M. Tibolone in postmenopausal women with a history of breast carcinoma. Journal of the British menopause society, 1995 October: 24-25.
13. GOODWIN P. J., ENNIS M., PRITCHARD K. I., TRUDEAU M., HOOD N. Risk of menopause during the first year after breast cancer diagnosis. Clin Oncol, 1999, 17: 82365-2370.
14. HARRIS P. F., REMINGTON P. L.. TRENTHAM- DIETZ A., ALLEN C. I,. NEWCOMB P. A. Prevalence and treatment of menopausal symptoms among breast cancer survivors. J Pain Symptom Manage. 2002, 23: 6501-509.
15. HICKEY M., SAUNDERS C. M., STUCKEY B. G. Management of menopausal symptoms in patients with breast cancer : an evidence-based approach. Lancet Oncol, 2005, 6: 9687-695.
16. HODA D., PEREZ D. G., LOPRINZI C. L. Hot flushes in breast cancer survivors. Breast J, 2003 Sep-Oct, 9 (5): 431-8.
17. HOLMBERG L., ANDERSON H. HABITS steering and data monitoring committees. HABITS (hormonal replacement therapy after breast cancer - is it safe ?), a randomised comparison : trial stopped. Lancet, 2004, 363: 9407453-455.
18. KANIS J. A., MCCLOSKEY E.V., POWLES T., PATERSON A. H., ASHLEY S., SPECTOR T. A high incidence of vertebral fracture in women with breast cancer. Br J Cancer, 1999 Mar, 79 (7-8): 1179-81.
19. KROISS R., FENTIMAN I. S., HELMOND F. A., RYMER J., FOIDART J. M., BUNDRED N., MOL-ARTS M., KUBISTA E. The effect of tibolone in postmenopausal women receiving tamoxifen after surgery for breast cancer : a randomised, double-blind, placebo-controlled trial. BJOG : An International Journal of Obstetrics & Gynaecology, 2005 Feb. 112 (2) : 228-33.
20. LOPRINZI C. L., MICHALAK J. C., QUELLA S. K., O'FALLON J. R., HATFIELD A. K., NELIMARK R. A., DOSE A. M., FISCHER T., JOHNSON C, KLATT N. E. et al. Megestrol acetate for the prevention of hot flushes. N Engl J Med, 1994 Aug 11, 331 (6) : 347-52.
21. LOPRINZI C. L., ABU-GHAZALEH S., SLOAN J. A., VAN HAELST-PISANI C., HAMMER A. M., ROWLAND K. M. Jr., LAW M., WINDSCHITL H. E., KAUR J. S., ELUSON N. Phase III randomized double-blind study to evaluate the efficacy of a polycarbophilbased vaginal moisturizer in women with breast cancer. J Clin Oncol, 1997 Mar, 15 (3): 969-73.
22. LOPRINZI C. L., KUGLER J. W., SLOAN J. A., MAILLIARD J. A., LAVASSEUR B. I., BARTON D. L., NOVOTNY P. J., DAKHIL S. R., RODGER K., RUMMANS T. A., CHRISTENSEN B. J. Venlafaxinc in management of hot flushes in survivors of breast cancer : a randomised controlled trial. Lancet, 2000 Dec 16, 356 (9247): 2059-63.
23. LOPRINZI C. L., SLOAN J. A., PEREZ E. A., QUELLA S. K., STELLA P. J., MAILLIARD J. A., HALYARD M. Y., PRUTHI S., NOVOTNY P. J., RUMMANS T. A. Phase III evaluation of fluoxetine for treatment of hot flushes. J Clin Oncol, 2002 Mar 15, 20 (6): 1578-83.
24. LOPRINZI C. L., LEVITT R., BARTON D., SLOAN J. A., DAKHIL S. R., NIKCEVICH D. A., BEARDEN J. D. 3rd., MAILLIARD J. A., TSCHETTER L. K., FITCH T. R., KUGLER J. W. Phase III comparison of depomedroxyprogesterone acetate to venlafaxine for managing hot flushes : North Central Cancer Treatment Group Trial N99C7. J Clin Oncol, 2006 Mar 20, 24 (9): 1409-14. Epub 2006 Feb 27.
25. LOWER E. E., BLAU R., GAZDER P., TUMMALA R. The risk of premature menopause induced by chemotherapy for early breast cancer. J Women s Health Gend Based Med, 1999, 8 : 7949-954.
26. Me CLOSKEY. The effects of third-generation aromatase inhibitors on bone. EurJ Cancer, 2006 May, 42 (8): 1044-51.
27. NIKANDER E., KILKKINEN A., METSA- HEIKKILA M., ADLERCREUTZ H., PIETINEN P., TIITINEN A., YLIKORKALA O. A randomized placebocontrolled crossover trial with phyto-oestrogens in the treatment of menopause in breast cancer patients. Obstet Gynecol, 2003 Jun, 101 (6): 1213-20.
28. PANDYA K. J., RAUBERTAS R. F., FLYNN P. J., HYNES H. E., ROSENBLUTH R. J., KIRSHNER J. J., PIERCE H. I., DRAGALIN V., MORROW G. R. Oral clonidine in postmenopausal patients with breast cancer experiencing tamoxifen-induced hot flushes: a University of Rochester Cancer Center Community Clinical Oncology Program study. Ann Intern Med, 2000 May 16, 132 (10): 788-93.
29. PANDYA K. J., MORROW G. R., ROSCOE J. A., ZHAO H., HICKOK J. T., PAJON E., SWEENEY T. J., BANERJEE T. K., FLYNN P. J. Gabapentin for hot flushes in 420 women with breast cancer : a randomised double-blind placebo-controlled trial. Lancet, 2005 Sep 3-9, 366 (9488): 818-24.
30. PATERSON. Evaluating bone mass and bone quality in patients with breast cancer. Clin Breast Cancer, 2005 Feb, 5 Suppl (2): S41-5,
31. REDDY S. Y., WARNER H., GUTTUSO T. Jr.., MESSING S., DIGRAZIO W., THORNBURG L., GUZICK D. S. Gabapentin, oestrogen and placebo for treating hot flushes : a randomized controlled trial. Obstet Gynaecol, 2006 Jul, 108 (1): 41-8.
32. VON SCHOULTZ E., RUTQVIST L. E. Stockholm Breast Cancer Study Group. Menopausal hormone therapy after breast cancer : the Stockholm randomized trial. J Natl Cancer Inst, 2005, 97: 7533-5.
33. STEARNS V., BEEBE K. L., IYENGAR M., DUBE E. Paroxetine controlled release in the treatment of menopausal hot flushes: a randomised controlled trial. JAMA, 2003 Jun 4, 289 (21): 2827-34.
34. STEARNS V., JOHNSON M. D., RAE J. M., MOROCHO A., NOVIELLI A., BHAROAVA P., HAYES D. F., DESTA Z., FLOCKHART D. A. Active tamoxifen metabolite plasma concentrations after co-administration of tamoxifen and the selective serotonin re-uptake inhibitor paroxetine. J Natl Cancer Inst, 2003 Dec 3, 95 (23): 1758-64.